Literature DB >> 14567794

Screening of natural products extracts for the presence of phosphodiesterase inhibitors using liquid chromatography coupled online to parallel biochemical detection and chemical characterization.

T Schenk1, G J Breel, P Koevoets, S van den Berg, A C Hogenboom, H Irth, U R Tjaden, J van der Greef.   

Abstract

The ability to rapidly identify active compounds in a complex mixture (e.g., natural products extract) is still one of the major problems in natural products screening programs. An elegant way to overcome this problem is to separate the complex mixture by gradient liquid chromatography followed by online biochemical detection parallel with chemical characterization, referred to as high-resolution screening (HRS). To find and identify phosphodiesterase (PDE) inhibitors in natural products extracts using the HRS technology, the authors developed a continuous-flow PDE enzymatic assay. The suitability of the continuous-flow PDE enzymatic assay for natural products screening was demonstrated. After optimization of the continuous-flow PDE assay, the limit of detection for 3-isobutyl-1-methyl-xanthine (IBMX) was 1 muM, with a dynamic range from 1 to 100 muM IBMX. The applicability of the HRS technology for the detection of PDE inhibitors in natural products extracts was demonstrated by the analysis of a plant extract spiked with 2 naturally occurring PDE inhibitors. The plant extract was analyzed with 2 assay lines in parallel, enabling background fluorescence correction of the sample. The simultaneous quantification of the active compounds using evaporative light-scattering detection allowed the estimation of the IC(50) value of the active compounds directly in the crude extract.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567794     DOI: 10.1177/1087057103255973

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  7 in total

1.  Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.

Authors:  Alexandre Maciuk; Ruin Moaddel; Jun Haginaka; Irving W Wainer
Journal:  J Pharm Biomed Anal       Date:  2007-11-26       Impact factor: 3.935

2.  Development and validation of a transcreener assay for detection of AMP- and GMP-producing enzymes.

Authors:  Matt Staeben; Karen M Kleman-Leyer; Andrew L Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  Assay Drug Dev Technol       Date:  2010-06       Impact factor: 1.738

Review 3.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

4.  A unifying review of bioassay-guided fractionation, effect-directed analysis and related techniques.

Authors:  Michael G Weller
Journal:  Sensors (Basel)       Date:  2012-07-04       Impact factor: 3.576

Review 5.  Advances in mass spectrometry-based post-column bioaffinity profiling of mixtures.

Authors:  Jeroen Kool; Martin Giera; Hubertus Irth; Wilfried M A Niessen
Journal:  Anal Bioanal Chem       Date:  2010-11-24       Impact factor: 4.142

Review 6.  Development of on-line high performance liquid chromatography (HPLC)-biochemical detection methods as tools in the identification of bioactives.

Authors:  Christiaan J Malherbe; Dalene De Beer; Elizabeth Joubert
Journal:  Int J Mol Sci       Date:  2012-03-07       Impact factor: 6.208

7.  A Comprehensive 2D-LC/MS Online Platform for Screening of Acetylcholinesterase Inhibitors.

Authors:  Claudia Seidl; Juliana Maria de Lima; Gabriel Mazzi Leme; Ananda Ferreira Pires; Dwight R Stoll; Carmen Lúcia Cardoso
Journal:  Front Mol Biosci       Date:  2022-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.